A new assay is inexpensive, simple, and can tell whether or not one of the primary drugs being used to treat malaria is genuine – an enormous and deadly problem in the developing world.

The World Health Organization has estimated that up to 200,000 lives a year may be lost due to the use of counterfeit anti-malarial drugs. When commercialized, the new technology may be able to help address that problem by testing drugs for efficacy at a cost of a few cents.


The "colorimetric" assay can be used to tell whether or not people are getting the medication they paid for – artesunate - which is by far the most important drug used to treat serious cases of malaria.  What kind of miscreant sells fake malaria drugs? Lots of countries banned DDT, and that killed a lot more people than a fake drug has.

The assay also verifies that an adequate level of the drug is present and, if implemented, might save thousands of lives every year around the world, and similar technology could also be developed for other types of medications and diseases.



This approach is used to prepare a paper assay that can tell whether a common drug used to treat malaria is genuine. Graphic courtesy of Oregon State University

"There are laboratory methods to analyze medications such as this, but they often are not available or widely used in the developing world where malaria kills thousands of people every year," said Vincent Remcho, a professor of chemistry at Oregon State University. "What we need are inexpensive, accurate assays that can detect adulterated pharmaceuticals in the field, simple enough that anyone can use them. Our technology should provide that."

In some places in the developing world, more than 80 percent of outlets are selling counterfeit pharmaceuticals, researchers have found. One survey found that 38-53 percent of outlets in Cambodia, Laos, Myanmar, Thailand and Vietnam had no active drug in the product that was being sold. Artesunate, which can cost $1 to $2 per adult treatment, is considered an expensive drug by the standards of the developing world, making counterfeit drugs profitable since the disease is so prevalent.

Besides allowing thousands of needless deaths, the spread of counterfeit drugs with sub-therapeutic levels of artesunate can promote the development of new strains of multi-drug resistant malaria, with global impacts. Government officials could also use the new system as a rapid screening tool to help combat the larger problem of drug counterfeiting.

The new technology is an application of microfluidics, in this instance paper microfluidics, in which a film is impressed onto paper that can then detect the presence and level of the artesunate drug. A single pill can be crushed, dissolved in water, and when a drop of the solution is placed on the paper, it turns yellow if the drug is present. The intensity of the color indicates the level of the drug, which can be compared to a simple color chart.

OSU undergraduate and graduate students in chemistry and computer science working on this project in the Remcho lab took the system a step further, and created an app for an iPhone that could be used to measure the color, and tell with an even higher degree of accuracy both the presence and level of the drug.

The technology is similar to what can be accomplished with computers and expensive laboratory equipment, but is much simpler and less expensive. As a result, use of this approach may significantly expand in medicine, scientists said.

"This is conceptually similar to what we do with integrated circuit chips in computers, but we're pushing fluids around instead of electrons, to reveal chemical information that's useful to us," Remcho said. "Chemical communication is how Mother Nature does it, and the long term applications of this approach really are mind-blowing."

Colorimetric assays have already been developed for measurement of many biomarker targets of interest, Remcho said, and could be expanded for a wide range of other medical conditions, pharmaceutical and diagnostic tests, pathogen detection, environmental analysis and other uses.

With a proof of concept of the new technology complete, the researchers may work with the OSU Advantage to commercialize the technology, ultimately with global application. As an incubator for startup and early stage organizations, OSU Advantage connects business with faculty expertise and student talent to bring technology such as this to market.


 Published in Talanta. Source: Oregon State University